Similarly, Akkermansia muciniphila administration mitigated obesity-associated alterations by protecting the gut barrier via mucus production, Toll-like-receptor (TLR)2 signalling18 and increased glucagon-like peptide 1 (GLP-1) secretion19. The gene discussed is TLR2; the disease is obesity disorder.